Business description
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.
Management board & Supervisory board
| CEO |
| Kevin Sayer |
| Management board |
| Jereme Sylvain, Andrew K. Balo, Barry Regan, Chad Patterson, Don Abbey, Jake Leach, Paul Flynn, Sadie Stern, Shelly Selvaraj, Steven R. Pacelli, Sumi Shrishrimal |
| Supervisory board |
| Kevin Sayer, Barbara E. Kahn, Bridgette Heller, Eric J. Topol, M.D., Jay Skyler, M.D., Karen Dahut, Kyle Malady, Mark Foletta, Nick Augustinos, Richard Collins, Steven R. Altman |
Company data
| Name: |
Dexcom Inc. |
| Address: |
6340 Sequence Drive,San Diego, CA 92121, USA |
| Phone: |
+1-858-200-0200 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.dexcom.com/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
31/12 |
| Free Float: |
- |
| IPO date: |
- |
